Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis

Background Fibroblast growth factor-23 (FGF-23) has been hypothesized to play a role in the increased risk of cardiovascular disease in patients with CKD. Methods We identified prospective studies reporting associations between FGF-23 concentration and risk of cardiovascular events. Maximally adjust...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Soc Nephrol
Egile Nagusiak: Marthi, Amarnath, Donovan, Killian, Haynes, Richard, Wheeler, David C., Baigent, Colin, Rooney, Christopher M., Landray, Martin J., Moe, Sharon M., Yang, Jun, Holland, Lisa, di Giuseppe, Romina, Bouma-de Krijger, Annet, Mihaylova, Borislava, Herrington, William G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2018
Gaiak:
Meta-Analysis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6050929/
https://ncbi.nlm.nih.gov/pubmed/29764921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2017121334
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak